Provided by Tiger Trade Technology Pte. Ltd.

iShares Genomics Immunology and Healthcare ETF

39.67
-0.4100-1.02%
Volume:143.91K
Turnover:5.68M
Market Cap:247.94M
PE:- -
High:39.84
Open:39.76
Low:39.00
Close:40.08
52wk High:40.86
52wk Low:22.12
Shares:6.25M
Float Shares:6.25M
Volume Ratio:1.29
T/O Rate:2.30%
Dividend:0.28
Dividend Rate:0.71%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Femasys announces FDA approval of FemBloc modular premarket approval application

TIPRANKS
·
Aug 19

Sector Update: Healthcare

MT Newswires Live
·
Aug 19

William Blair Upgrades Moderna to Outperform From Market Perform

MT Newswires Live
·
Aug 19

US Stocks-Wall St Set for Higher Open After Retail Earnings; Moderna Soars

Reuters
·
Aug 19

Moderna extends rally, shares up 89% to $118.99 after melonoma data

TIPRANKS
·
Aug 19

Moderna upgraded to Outperform from Market Perform at William Blair

TIPRANKS
·
Aug 19

Biotech Stocks Jump Premarket After Moderna's Melanoma Vaccine with Merck Succeeds in Large Trial

THOMSON REUTERS
·
Aug 19

The Bond Selloff is Rattling Investors, but Here's Why They Shouldn't Expect a Deeper Stock Downturn

Dow Jones
·
Aug 19

Moderna Shares More than Double Premarket; Last up 103%

THOMSON REUTERS
·
Aug 19

Stocks to Watch: Oracle, SK Hynix, Moderna, Unitree

Dow Jones
·
Aug 19

US Stocks-Wall St Futures Flat After Tech Rout; Iran Tensions, Retail Earnings in Focus

Reuters
·
Aug 19

Moderna, Merck, La-Z-Boy, SK Hynix, and More Stocks That Explain Today's Market

Dow Jones
·
Aug 19

U.S. Stocks on the MOVE-Estee Lauder, Target, Analog Devices

Reuters
·
Aug 19

Twist Bioscience Assists Anthropic in Testing Whether Claude Can Accelerate Drug-Design Process

Dow Jones
·
Aug 19

Merck, Moderna Say Potential Melanoma Therapy Shows 'Statistically Significant Improvement' in Late-Stage Trial

MT Newswires Live
·
Aug 19

Bond Yields, Persian Gulf Outlooks Cap Wall Street Pre-Bell; Asia, Europe Off

MT Newswires Live
·
Aug 19

Moderna Stock Surges 70%, Merck Rises 6%. at Last, a Successful Cancer Vaccine.

Dow Jones
·
Aug 19

Moderna and Merck Say Melanoma Skin Cancer Vaccine Meets Goals in Large Trial

Reuters
·
Aug 19

Moderna Vaccine Cuts Recurrence and Spread of High-Risk Melanoma, Raising New Treatment Hope

Reuters
·
Aug 19

Moderna jumps 54% to $97.52 after Phase 3 INTerpath-001 trial met endpoints

TIPRANKS
·
Aug 19